TNGX

Tango Therapeutics, Inc.

There isn't enough reported data to score TNGX yet.

UNH

UnitedHealth Group Incorporated

62
Fundamentals51/ 100
Valuation56/ 100
Upside potential71/ 100
Risk potential15/ 100

UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.

TNGX Fundamentals

MetricStatus
Weak
Weak
Unavailable
Unavailable

TNGX's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.

UNH Fundamentals

MetricStatus
Stable
Stable
Healthy
Healthy

UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

TNGX PE Valuation

TNGX has no meaningful PE right now: it lost money over the past year.

UNH PE Valuation

CHEAPFAIREXPENSIVE10x21x31x42x
CHEAPFAIREXPENSIVE10x21x31x42x
LevelPEPriceVs current
Forward18x$405—
Cheap19x$325-20%
Fair23x$410+1.2%
Current23x$405—
Expensive30x$526+30%

Historical ranges are pointers, not guarantees.

UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

TNGX Forward outlook

MetricOutlook
--
Losses growing
Strong decline
--
Limited
Low

Analysts expect TNGX's losses to grow, with revenue declining. However, they disagree widely on these estimates.

UNH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Stable
Improving
Moderate
Low

Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

TNGX Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $24.85 on Nov 12.

There is not enough scenario data to compare TNGX and UNH's risk to reward.

UNH Risk to reward

ScenarioChangePrice
Upside+36%$550.65
Downside-15%$346.07

Calculated from the latest close: $405.13 on Nov 12.

There is not enough scenario data to compare TNGX and UNH's risk to reward.

TNGX Earnings Per Share

Q4 2023: $-1.08Q1 2024: $-1.11Q2 2024: $-1.12Q3 2024: $-1.16Q4 2024: $-1.19Q1 2025: $-1.20Q2 2025: $-1.31Q3 2025: $-0.91Q4 2025: $-0.87Q1 2026: $-0.83Q2 2026: $-0.85Q3 2026: $-1.37
Q4 2023: $-1.08Q1 2024: $-1.11Q2 2024: $-1.12Q3 2024: $-1.16Q4 2024: $-1.19Q1 2025: $-1.20Q2 2025: $-1.31Q3 2025: $-0.91Q4 2025: $-0.87Q1 2026: $-0.83Q2 2026: $-0.85Q3 2026: $-1.37
QuarterTTM EPSYoY
Q3 2026-$1.37-$0.46
Q2 2026-$0.85+$0.46
Q1 2026-$0.83+$0.37
Q4 2025-$0.87+$0.32
Q3 2025-$0.91+$0.25
Q2 2025-$1.31-$0.19
Q1 2025-$1.20-$0.09
Q4 2024-$1.19-$0.11

TNGX lost $1.37 per share over the past year, a bigger loss than the year before.

UNH Earnings Per Share

Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
QuarterTTM EPSYoY
Forward$22.65+29%
Q3 2026$17.55-8.5%
Q2 2026$15.58-33%
Q1 2026$13.28-44%
Q4 2025$13.23-15%
Q3 2025$19.17+25%
Q2 2025$23.09+53%
Q1 2025$23.89+46%
Q4 2024$15.51-35%

UNH has the edge over TNGX on earnings quality, reporting a profit while its opponent remains loss making.

TNGX Quarterly Revenue

Q4 2023: $5MQ1 2024: $6MQ2 2024: $20MQ3 2024: $12MQ4 2024: $4MQ1 2025: $5MQ2 2025: $3MQ3 2025: $54MQ4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: $0
Q4 2023: $5MQ1 2024: $6MQ2 2024: $20MQ3 2024: $12MQ4 2024: $4MQ1 2025: $5MQ2 2025: $3MQ3 2025: $54MQ4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: $0
QuarterRevenueYoY
Q3 2025$53.8M+364%
Q2 2025$3.2M-84%
Q1 2025$5.4M-17%
Q4 2024$4.1M-24%
Q3 2024$11.6M+8.2%
Q2 2024$19.9M+36%
Q1 2024$6.5M+12%
Q4 2023$5.4M-15%

TNGX's revenue has slid since its 2025 peak: $0 last quarter, down 100% from the same quarter a year ago.

UNH Quarterly Revenue

Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
QuarterRevenueYoY
Q3 2026$112.7B-0.4%
Q2 2026$112B+0.4%
Q1 2026$111.7B+2%
Q4 2025$113.2B+12%
Q3 2025$113.2B+12%
Q2 2025$111.6B+13%
Q1 2025$109.6B+9.8%
Q4 2024$100.8B+6.8%

UNH has the edge over TNGX on sales, with more consistent year-over-year improvement.

TNGX Free Cash Flow

Q4 2023: −$28MQ1 2024: −$38MQ2 2024: −$24MQ3 2024: −$34MQ4 2024: −$37MQ1 2025: −$42MQ2 2025: −$37MQ3 2025: −$31MQ4 2025: −$30MQ1 2026: −$44MQ2 2026: −$39MQ3 2026: −$37M
Q4 2023: −$28MQ1 2024: −$38MQ2 2024: −$24MQ3 2024: −$34MQ4 2024: −$37MQ1 2025: −$42MQ2 2025: −$37MQ3 2025: −$31MQ4 2025: −$30MQ1 2026: −$44MQ2 2026: −$39MQ3 2026: −$37M
QuarterFree cash flowYoY
Q3 2026-$37.2M-$6.1M
Q2 2026-$38.9M-$1.7M
Q1 2026-$44.4M-$2.6M
Q4 2025-$29.9M+$6.8M
Q3 2025-$31.1M+$2.4M
Q2 2025-$37.1M-$13.2M
Q1 2025-$41.7M-$3.7M
Q4 2024-$36.8M-$9.1M

TNGX has burned cash in almost every quarter: −$150M over the past year, against −$147M the year before.

UNH Free Cash Flow

Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
QuarterFree cash flowYoY
Q3 2026$4.3B-16%
Q2 2026$10.3B+63%
Q1 2026$8.1B+79%
Q4 2025$160M-89%
Q3 2025$5.1B-61%
Q2 2025$6.3B+6.9%
Q1 2025$4.6B+1037%
Q4 2024$1.5B+$7.6B

UNH has the edge over TNGX on cash generation, producing positive trailing cash flow while its opponent burns cash.

TNGX Total Shares

Q4 2023: 95MQ1 2024: 108MQ2 2024: 108MQ3 2024: 109MQ4 2024: 109MQ1 2025: 110MQ2 2025: 111MQ3 2025: 118MQ4 2025: 116MQ1 2026: 144MQ2 2026: 150MQ3 2026: 174M
Q4 2023: 95MQ1 2024: 108MQ2 2024: 108MQ3 2024: 109MQ4 2024: 109MQ1 2025: 110MQ2 2025: 111MQ3 2025: 118MQ4 2025: 116MQ1 2026: 144MQ2 2026: 150MQ3 2026: 174M
PeriodChange %Net change
Quarterly+16%+24.1M shares
1 year+48%+56.1M shares
3 years+79%+76.9M shares
5 years+3599%+169M shares

TNGX has 174M diluted shares, up 48% from a year ago.

UNH Total Shares

Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
PeriodChange %Net change
Quarterly-0.4%-4M shares
1 year-0.7%-6M shares
3 years-3.6%-34M shares
5 years-5.5%-53M shares
Available history-6.6%-64M shares

UNH has the edge over TNGX on shareholder dilution, with a more favorable share count trend.

TNGX Net Leverage

TNGX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

UNH Net Leverage

Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.7xHealthy
Q1 20262.2xModerate
Q4 20252.3xModerate
Q3 20251.7xHealthy
Q2 20251.5xHealthy
Q1 20251.3xHealthy
Q4 20241.4xHealthy

UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.

TNGX Weekly Momentum

MetricValueStatus
RSI53.8Neutral
Stochastic27.6Neutral

TNGX's weekly RSI is 54 (neutral) and its Stochastic is 28 (neutral).

UNH Weekly Momentum

MetricValueStatus
RSI56.4Neutral
Stochastic60.0Neutral

UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).

TNGX PE vs Healthcare Sector

TNGX has no meaningful PE right now: it lost money over the past year.

UNH PE vs Healthcare Sector

MetricUNHSector medianRelative
PE23x26x11% below
PE %472918 pts above

UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.

TNGX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$23.36.7% above
20 week MA$24.90% below
50 week MA$20.521% above
100 week MA$12.697% above
200 week MA$9.89151% above

TNGX's trend is mixed: it's above four of its five weekly moving averages, and 151% above its 200-week average.

UNH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$394.22.8% above
20 week MA$400.51.2% above
50 week MA$361.212% above
100 week MA$376.07.8% above
200 week MA$446.69.3% below

UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.

TNGX Yearly ROI

YearStart priceEnd priceROI
2020$10.3$11.3+9.9%
2021$11.3$10.9-2.8%
2022$10.9$7.83-28%
2023$7.83$9.90+26%
2024$9.90$3.12-68%
2025$3.12$8.67+178%
2026 YTD$8.67$24.9+187%

TNGX has the edge over UNH on returns for 2026, with the stronger performance.

UNH Yearly ROI

YearStart priceEnd priceROI
2020$296.0$340.8+15%
2021$340.8$495.4+45%
2022$495.4$531.3+7.3%
2023$531.3$526.5-0.9%
2024$526.5$510.0-3.1%
2025$510.0$331.8-35%
2026 YTD$331.8$405.1+22%

UNH has finished three years in a row lower, and it's up 22% so far in 2026.

Give your agent the market.

Get API key